• Summary

    Therapeutic targeting of deregulated genetic network of insulin resistance may open a new hope for treating T2DM that is very common in Egypt. We will perform a computational analysis to retrieve lncRNA-associated ceRNAs involved in T2DM , validate in patients’ and cell line. We will evaluate gene editing as a potential therapeutic strategy to modulate the expression of deregulated network in T2DM. Meanwhile, we will transfer gene editing technology to junior researchers

  • Achievements


  • List of Publications from the Project


  • Partners

  • Project Members

  • Project Leaders

  • Project PI

    Sanaa Eissa

  • Faculty

    Faculty of Medicine

  • Research Group

  • Funding Agency

    Academy of Scientific Research & Technology (ASRT)

  • Funding Program

    JESOR

  • Start Date

    2018-10-18

  • End Date

    2021-03-09

  • Sustainable Development Goals (SDGs)

    • 3: Good Health and Well-being
  • Project website